All In Biotech

Drug Trial Radar · NCT06023589

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON)

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 231 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

231

Planned (sponsor's estimate)

Start

Aug 24, 2023

Primary completion

May 31, 2028

Study completion Aug 23, 2030

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
Collaborators
Amgen
First posted
Sep 5, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.

Conditions

  • Asthma

Interventions

  • TezepelumabBiological

    Participants will be receiving subcutaneous injection of tezepelumab

  • PlaceboOther

    Participants will be receiving subcutaneous injection of matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized severe asthma exacerbation rate (AAER)Time frame: From Baseline to Week 52

Locations

147 sites in 22 countries. Site status is shown where the registry gives one.

  • Research Site

    Montgomery, Alabama · Recruiting

  • Research Site

    Phoenix, Arizona · Recruiting

  • Research Site

    Little Rock, Arkansas · Withdrawn

  • Research Site

    La Jolla, California · Active not recruiting

  • Research Site

    Long Beach, California · Recruiting

  • Research Site

    Orange, California · Withdrawn

  • Research Site

    San Diego, California · Recruiting

  • Research Site

    Atlanta, Georgia · Recruiting

  • Research Site

    Savannah, Georgia · Terminated

  • Research Site

    Baltimore, Maryland · Recruiting

  • Research Site

    Boston, Massachusetts · Recruiting

  • Research Site

    Boston, Massachusetts · Recruiting

  • Research Site

    Ann Arbor, Michigan · Terminated

  • Research Site

    Detroit, Michigan · Recruiting

  • Research Site

    Northfield, New Jersey · Recruiting

  • Research Site

    Hawthorne, New York · Recruiting

  • Research Site

    Schenectady, New York · Withdrawn

  • Research Site

    Staten Island, New York · Recruiting

  • Research Site

    Chapel Hill, North Carolina · Recruiting

  • Research Site

    Cincinnati, Ohio · Recruiting

  • Research Site

    Cleveland, Ohio · Recruiting

  • Research Site

    Toledo, Ohio · Recruiting

  • Research Site

    Oklahoma City, Oklahoma · Recruiting

  • Research Site

    Columbia, South Carolina · Withdrawn

  • Research Site

    Coppell, Texas · Terminated

  • Research Site

    Dallas, Texas · Recruiting

  • Research Site

    Frisco, Texas · Withdrawn

  • Research Site

    Houston, Texas · Recruiting

  • Research Site

    San Antonio, Texas · Recruiting

  • Research Site

    Temple, Texas · Withdrawn

  • Research Site

    Buenos Aires, Argentina · Recruiting

  • Research Site

    Buenos Aires, Argentina · Recruiting

  • Research Site

    Buenos Aires, Argentina · Recruiting

  • Research Site

    CABA, Argentina · Terminated

  • Research Site

    Florida, Argentina · Recruiting

  • Research Site

    Lanus, Argentina · Recruiting

  • Research Site

    Lobos, Argentina · Recruiting

  • Research Site

    Mendoza, Argentina · Recruiting

  • Research Site

    Quilmes, Argentina · Terminated

  • Research Site

    Rosario, Argentina · Recruiting

Showing 40 of 147 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.